| BE0341-25MG
| InVivoMAb anti-human EphA2
| 25 mg
| BioXCell
| Immunohistochemistry (paraffin), Immunoprecipitati
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0323-100MG
| InVivoMAb anti-mouse TL1A (TNFSF15)
| 100 mg
| BioXCell
| in vivo TL1A neutralization, Flow cytometry
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0319-50MG
| InVivoMAb anti-mouse FasL (CD178)
| 50 mg
| BioXCell
| in vivo FasL blockade, In vitro FasL blockade, Fun
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0313-25MG
| InVivoMAb anti-mouse IL-23 (p19)
| 25 mg
| BioXCell
| in vivo IL-23p19 neutralization, Western blot
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0306-5MG
| InVivoMAb anti-human/monkey MHC class II (HLA-DR)
| 5 mg
| BioXCell
| in vitro blocking of MHC class II HLA-DR, HLA clas
|
| Mouse
| Human, Monkey
| Solicitar Precio
| Solicitar
|
| BE0373-5MG
| InVivoMAb anti-mouse osteopontin (SPP1)
| 5 mg
| BioXCell
| in vivo OPN neutralization, in vitro OPN neutraliz
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0370-25MG
| InVivoMAb anti-human CD71 (TfR1)
| 25 mg
| BioXCell
| Flow cytometry, Immunoprecipitation
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0329-5MG
| InVivoMAb anti-mouse CD71 (TfR1)
| 5 mg
| BioXCell
| in vivo depletion of CD71+ cells, Immunofluorescen
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0369-100MG
| InVivoMAb polyclonal llama IgG
| 100 mg
| BioXCell
|
|
| Llama
|
| Solicitar Precio
| Solicitar
|
| BE0374-50MG
| InVivoMAb anti-mouse FAP
| 50 mg
| BioXCell
| Chimeric antigen receptor construction, Flow cytom
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0303-25MG
| InVivoMAb anti-mouse IL-17F
| 25 mg
| BioXCell
| in vivo IL-17F neutralization
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0301-50MG
| InVivoMAb human IgG2 isotype control
| 50 mg
| BioXCell
|
|
| Human
|
| Solicitar Precio
| Solicitar
|
| BE0338-1MG
| InVivoMAb anti-human CD220 (Insulin Receptor)
| 1 mg
| BioXCell
| Western blot
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0355-5MG
| InVivoMAb anti-human CA19-9
| 5 mg
| BioXCell
| Immunohistochemistry (paraffin), Immunofluorescenc
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0298-5MG
| InVivoMAb anti-mouse CD122 (IL-2R?)
| 5 mg
| BioXCell
| in vivo NK cell depletion, in vivo CD122 blockade,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0373-1MG
| InVivoMAb anti-mouse osteopontin (SPP1)
| 1 mg
| BioXCell
| in vivo OPN neutralization, in vitro OPN neutraliz
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0308-100MG
| InVivoMAb anti-rat CD4
| 100 mg
| BioXCell
| in vivo CD4+ T cell depletion, Flow cytometry
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|
| BE0315-10MG
| InVivoMAb anti-mouse IL-15
| 10 mg
| BioXCell
| in vivo IL-15 neutralization, in vitro IL-15 neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0305-25MG
| InVivoMAb anti-mouse CLEC9A (CD370)
| 25 mg
| BioXCell
| in vivo CLEC9A blockade, in vivo Ag targeting to C
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0354-100MG
| InVivoMAb anti-human CD2
| 100 mg
| BioXCell
| in vivo CD2 blockade in huCD2tg mice
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0374-100MG
| InVivoMAb anti-mouse FAP
| 100 mg
| BioXCell
| Chimeric antigen receptor construction, Flow cytom
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0376-25MG
| InVivoMAb anti-human CD71 (TfR1)
| 25 mg
| BioXCell
| Flow cytometry*, Immunoprecipitation*, Western blo
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0374-5MG
| InVivoMAb anti-mouse FAP
| 5 mg
| BioXCell
| Chimeric antigen receptor construction, Flow cytom
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0327-50MG
| InVivoMAb anti-human IL-9
| 50 mg
| BioXCell
| Flow cytometry, ELISA
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0362-100MG
| InVivoMAb anti-human CEACAM 1/3/5/6/8
| 100 mg
| BioXCell
| Western blot, ELISA, Immunofluorescence, Immunohis
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0338-5MG
| InVivoMAb anti-human CD220 (Insulin Receptor)
| 5 mg
| BioXCell
| Western blot
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0327-1MG
| InVivoMAb anti-human IL-9
| 1 mg
| BioXCell
| Flow cytometry, ELISA
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0379-1MG
| InVivoMAb anti-mouse TSLP
| 1 mg
| BioXCell
| in vivo TSLP neutralization, in vitro TSLP neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0304-5MG
| InVivoMAb anti-mouse BTLA (CD272)
| 5 mg
| BioXCell
| in vivo BTLA+ B cell and CD4 T cell depletion*, Fl
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0309-100MG
| InVivoMAb anti-mouse CXCL9 (MIG)
| 100 mg
| BioXCell
| in vivo CXCL9 neutralization, Immunofluorescence
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0355-100MG
| InVivoMAb anti-human CA19-9
| 100 mg
| BioXCell
| Immunohistochemistry (paraffin), Immunofluorescenc
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0367-50MG
| InVivoMAb anti-human CD71 (TfR1)
| 50 mg
| BioXCell
| in vitro CD71 targeting, in vivo CD71 targeting, I
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0303-5MG
| InVivoMAb anti-mouse IL-17F
| 5 mg
| BioXCell
| in vivo IL-17F neutralization
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0307-100MG
| InVivoMAb anti-mouse CD16/CD32
| 100 mg
| BioXCell
| in vitro Fc receptor blocking, in vivo Fc receptor
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0326-50MG
| InVivoMAb anti-mouse IL-27 p28
| 50 mg
| BioXCell
| in vivo IL-27 p28 neutralization, in vitro IL-27 p
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0377-5MG
| InVivoMAb anti-mouse CD31 (PECAM-1)
| 5 mg
| BioXCell
| in vivo CD31 blocking, Intravital imaging, Immunof
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0303-100MG
| InVivoMAb anti-mouse IL-17F
| 100 mg
| BioXCell
| in vivo IL-17F neutralization
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0368-100MG
| InVivoMAb anti-human/mouse/rat amyloid-beta
| 100 mg
| BioXCell
| Western blot, Immunohistochemistry, Immunofluoresc
|
| Mouse
| Human, Mouse, Rat
| Solicitar Precio
| Solicitar
|
| BE0373-100MG
| InVivoMAb anti-mouse osteopontin (SPP1)
| 100 mg
| BioXCell
| in vivo OPN neutralization, in vitro OPN neutraliz
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0334-1MG
| InVivoMAb anti-mouse NKG2D (CD314)
| 1 mg
| BioXCell
| in vivo NKG2D blockade, in vitro NKG2D blockade, F
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0336-50MG
| InVivoMAb anti-human MUC1 (CD227)
| 50 mg
| BioXCell
| in vivo administration in mouse xenograft models,
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0335-1MG
| InVivoMAb anti-human MAGE-C2 (CT10)
| 1 mg
| BioXCell
| Immunohistochemistry (paraffin), Immunofluorescenc
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0371-100MG
| InVivoMAb anti-mouse IL-12 p35
| 100 mg
| BioXCell
| in vivo IL-12 p35 neutralization, in vitro IL-12 p
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0342-25MG
| InVivoMAb recombinant Flt-3L-Ig (hum/hum)
| 25 mg
| BioXCell
|
|
|
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| BE0306-1MG
| InVivoMAb anti-human/monkey MHC class II (HLA-DR)
| 1 mg
| BioXCell
| in vitro blocking of MHC class II HLA-DR, HLA clas
|
| Mouse
| Human, Monkey
| Solicitar Precio
| Solicitar
|
| BE0330-25MG
| InVivoMAb anti-mouse CD69
| 25 mg
| BioXCell
| in vivo down-regulation of CD69 expression, Functi
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0340-100MG
| InVivoMAb anti-human/monkey MDR-1 (CD243)
| 100 mg
| BioXCell
| in vivo MDR-1 blocking/depletion in xenogeneic mur
|
| Mouse
| Human, Monkey
| Solicitar Precio
| Solicitar
|
| BE0348-1MG
| InVivoMAb anti-mouse CD27
| 1 mg
| BioXCell
| in vivo CD27 stimulation, in vitro CD27 stimulatio
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0339-25MG
| InVivoMAb anti-mouse NKG2AB6
| 25 mg
| BioXCell
| Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0310-5MG
| InVivoMAb anti-mouse VISTA
| 5 mg
| BioXCell
| in vivo blocking of VISTA signaling, in vitro bloc
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|